home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 11/19/21

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Biofrontera AG announces mediation results

Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in mediation proceedings with Mr. Wilhelm K. T. Zours and Deutsche Balaton AG for a year in order to find a solution for the settlement of legal ...
BFRA - Biofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2021 Results - Earnings Call Transcript

Biofrontera AG (BFRA) Q3 2021 Earnings Conference Call November 18, 2021, 08:00 AM ET Company Participants Pamela Keck - Head, IR Hermann Lübbert - CEO Ludwig Lutter - CFO Conference Call Participants Bruce Jackson - Benchmark Company Thomas Flaten - Lake Street Capital Markets Presentat...

BFRA - Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021

Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. K ...

BFRA - Biofrontera AG announces initiation of clinical studies

Leverkusen, Germany, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that two clinical studies for its prescription drug Ameluz ® in the United States...
BFRA - Biofrontera AG: Conference call to discuss third quarter 2021 financial results to be held on November 18, 2021

Leverkusen, Germany, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first nine months ended September 30, 2021 on We...

BFRA - Biofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp

Leverkusen, Germany, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced the approval of the new red-light source for photodynamic therapy (PDT), the BF-RhodoLED ® ...

BFRA - Biofrontera reports preliminary approximate revenues for the month of September 2021

Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of September 2021. The Company...
BFRA - Biofrontera reports preliminary revenue for the month of August 2021

Leverkusen, Germany, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of August 2021. The Company&#...

BFRA - Biofrontera AG's (BFRA) CEO Hermann Lübbert on Q2 2021 Results - Earnings Call Transcript

Biofrontera AG (BFRA) Q2 2021 Earnings Conference Call August 20, 2021, 8:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Ludwig Lutter - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Comp...

BFRA - Biofrontera reports financial results for the six months ended June 30, 2021

Leverkusen, Germany, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the six months ended June 30, 2021. K ey fi...
Previous 10 Next 10